Skip to Content

Cancers, Volume 16, Issue 14

2024 July-2 - 121 articles

Cover Story: The use of biomarker testing to inform cancer care decisions is increasing. Traditionally, biomarkers are measured from tumor samples obtained through tissue biopsies. However, this presents several challenges due to the risky and time-consuming nature of such a biopsy. A liquid biopsy is an emerging technique that uses a sample of peripheral blood to identify biomarker information. This non-invasive procedure can be used as an alternative or complementary approach to tissue-based testing. This article describes the experience of using a point of care liquid biopsy for cancer treatment at a community center. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (121)

  • Systematic Review
  • Open Access
3 Citations
5,726 Views
15 Pages

22 July 2024

Secondary cytoreductive surgery is a treatment option for relapsed platinum-sensitive epithelial ovarian cancer, but no clear indications are defined for the procedure. This systematic review aims to establish clear indications and compare outcomes v...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
3,460 Views
24 Pages

Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine

  • Marie Buchholz,
  • Britta Majchrzak-Stiller,
  • Ilka Peters,
  • Stephan Hahn,
  • Lea Skrzypczyk,
  • Lena Beule,
  • Waldemar Uhl,
  • Chris Braumann,
  • Johanna Strotmann and
  • Philipp Höhn

22 July 2024

The novel Oxathiazinane derivative GP-2250 (Misetionamide) displays antineoplastic activity in vitro and in vivo, as previously shown in pancreatic cancer cells and in patient-derived mouse xenografts (PDX). Currently, GP 2250 is under phase I clinic...

(This article belongs to the Section Cancer Drug Development)
  • Article
  • Open Access
8 Citations
5,307 Views
14 Pages

Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

  • Jonathan N. Priantti,
  • Maysa Vilbert,
  • Francisco Cezar Aquino de Moraes,
  • Thiago Madeira,
  • Evair Moisés de Lima Santiago,
  • Natasha B. Leighl,
  • Ludimila Cavalcante and
  • Nagla F. Abdel Karim

22 July 2024

Lorlatinib has been FDA-approved as a systemic therapy for ALK/ROS1-positive non-small cell lung cancer (NSCLC) patients. However, it has been associated with an increased frequency of neurocognitive adverse events (NAEs). Therefore, we conducted a s...

(This article belongs to the Special Issue Cancer-Therapy-Related Adverse Events)
  • Commentary
  • Open Access
8 Citations
3,069 Views
9 Pages

Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future Challenges

  • Diego Luigi Cortinovis,
  • Alessandro Leonetti,
  • Alessandro Morabito,
  • Luca Sala and
  • Marcello Tiseo

22 July 2024

Background: Targeted therapies changed the treatment of advanced oncogene-addicted non-small cell lung cancer and could also improve outcomes in resectable disease. Results: The ALINA trial evaluated the clinical benefit of adjuvant alectinib compare...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
10 Citations
7,088 Views
46 Pages

The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity

  • Ngoc Thien Thu Nguyen,
  • Rasmus Müller,
  • Daria Briukhovetska,
  • Justus Weber,
  • Judith Feucht,
  • Annette Künkele,
  • Michael Hudecek and
  • Sebastian Kobold

22 July 2024

Chimeric antigen receptor-T cells have spearheaded the field of adoptive cell therapy and have shown remarkable results in treating hematological neoplasia. Because of the different biology of solid tumors compared to hematological tumors, response r...

(This article belongs to the Special Issue CAR T Cell Therapy for Cancers)
  • Review
  • Open Access
11 Citations
5,322 Views
26 Pages

Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma

  • Stavros P. Papadakos,
  • Elena Chatzikalil,
  • Georgios Vakadaris,
  • Lampros Reppas,
  • Konstantinos Arvanitakis,
  • Theocharis Koufakis,
  • Spyros I. Siakavellas,
  • Spilios Manolakopoulos,
  • Georgios Germanidis and
  • Stamatios Theocharis

22 July 2024

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and presents a continuously growing incidence and high mortality rates worldwide. Besides advances in diagnosis and promising results of pre-clinical studies, established curative...

(This article belongs to the Special Issue Molecular Markers and Targeted Therapy for Hepatobiliary Tumors)
  • Editorial
  • Open Access
13 Citations
5,615 Views
4 Pages

22 July 2024

Traditional oncology image-analysis, using modalities such as echography, X-ray, CT, and MRI, has historically relied on human-defined features to interpret and assess clinical images [...]

(This article belongs to the Special Issue Recent Advances in Oncology Imaging)
  • Article
  • Open Access
3 Citations
3,069 Views
14 Pages

PD-L1 Expression in Paired Samples of Rectal Cancer

  • Mina Coussement,
  • Roberta Fazio,
  • Alessandro Audisio,
  • Reem El Khoury,
  • Fatima-Zahra Abbassi,
  • Irene Assaf,
  • Chiara Conti,
  • Chiara Gallio,
  • Nada Benhima and
  • Francesco Sclafani
  • + 9 authors

21 July 2024

Immune checkpoint inhibitors and immune-related biomarkers are increasingly investigated in rectal cancer (RC). We retrospectively analysed PD-L1 expression in diagnostic biopsy and resection samples from RC patients treated at our centre between 200...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
3 Citations
1,694 Views
12 Pages

Protective Effect of Minimally Invasive Approach on Postoperative Peak Transaminase Following Liver Resection: A Single-Center Propensity Score-Based Analysis

  • Francesco Ardito,
  • Sara Ingallinella,
  • Quirino Lai,
  • Francesco Razionale,
  • Davide De Sio,
  • Caterina Mele,
  • Simone Vani,
  • Maria Vellone and
  • Felice Giuliante

21 July 2024

Background: Postoperative serum ALT levels are one of the most frequently used marker to detect liver tissue damage following liver resection. The aim of this study was to evaluate if minimally invasive liver surgery (MILS) may result in less hepatic...

(This article belongs to the Special Issue The Evolving Treatment and Clinical Trials of Hepatocellular Carcinoma)
  • Article
  • Open Access
2 Citations
2,769 Views
24 Pages

Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines

  • Georgios Kalampounias,
  • Athina Varemmenou,
  • Christos Aronis,
  • Irene Mamali,
  • Athanasios-Nasir Shaukat,
  • Dionysios V. Chartoumpekis,
  • Panagiotis Katsoris and
  • Marina Michalaki

21 July 2024

Thyrotropin (TSH) suppression is required in the management of patients with papillary thyroid carcinoma (PTC) to improve their outcomes, inevitably causing iatrogenic thyrotoxicosis. Nevertheless, the evidence supporting this practice remains limite...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
5 Citations
2,886 Views
15 Pages

Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice

  • Song-Chang Lin,
  • Guoyu Yu,
  • Paul G. Corn,
  • Jossana Damasco,
  • Yu-Chen Lee,
  • Jian H. Song,
  • Nora M. Navone,
  • Christopher J. Logothetis,
  • Marites P. Melancon and
  • Sue-Hwa Lin
  • + 1 author

21 July 2024

Radium 223 (Ra-223) is an α-emitting bone-homing radiopharmaceutical that targets tumor-induced osteoblasts and is used to reduce bone pain and prolong overall survival in men with bone-metastatic, castrate-resistant prostate cancer. However, i...

(This article belongs to the Section Tumor Microenvironment)
  • Article
  • Open Access
1 Citations
1,641 Views
12 Pages

21 July 2024

Background: Brain metastases (BMs) frequently occur in cancer patients, and stereotactic radiation therapy (SRT) is a preferred treatment option. In this retrospective study, we analyzed patients treated by SRT for a single BM during their first SRT...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
1 Citations
2,195 Views
9 Pages

Sexual Function in Women Diagnosed with Hereditary Breast and Ovarian Cancer Syndrome

  • Federico Ferrari,
  • Juri Amonti,
  • Andrea Giannini,
  • Hooman Soleymani Majd,
  • Valentina Zizioli,
  • Giancarlo Tisi,
  • Luigi Della Corte,
  • Emma Bonetti,
  • Elisa Gozzini and
  • Franco Odicino

21 July 2024

Background: Hereditary breast and ovarian cancer syndrome (HBOC) predisposes women to an increased risk mainly of breast and tubo-ovarian cancer. The aim of the study is to investigate whether being diagnosed with HBOC syndrome is itself a risk facto...

(This article belongs to the Section Methods and Technologies Development)
  • Review
  • Open Access
10 Citations
8,648 Views
19 Pages

Incidental Findings in Lung Cancer Screening

  • Yenpo Lin,
  • Khulan Khurelsukh,
  • I-Gung Li,
  • Chen-Te Wu,
  • Yi-Ming Wu,
  • Gigin Lin,
  • Cheng-Hong Toh and
  • Yung-Liang Wan

20 July 2024

While low-dose computed tomography (LDCT) for lung cancer screening (LCS) has been recognized for its effectiveness in reducing lung cancer mortality, it often simultaneously leads to the detection of incidental findings (IFs) unrelated to the primar...

(This article belongs to the Special Issue Lung Cancer: From Mechanisms of Action and Risk Factors in Disease Onset to Management)
  • Article
  • Open Access
5 Citations
3,264 Views
12 Pages

Collection of Rare Peripheral Nerve Tumors—Insights from the German Registry

  • Nadja Grübel,
  • Gregor Antoniadis,
  • Anne-Kathrin Uerschels,
  • Oliver Gembruch,
  • Vera Marschal,
  • Stefanie Deininger,
  • Ralph König,
  • Andrej Pala,
  • Juliane Bremer and
  • Maria Teresa Pedro
  • + 3 authors

20 July 2024

The most common peripheral nerve tumors are of a benign nature and include schwannoma or neurofibroma. In rare cases, other tumors or non-tumorous lesions can mimic peripheral nerve tumors clinically or radiologically. Based on data from the multicen...

(This article belongs to the Section Cancer Pathophysiology)
  • Systematic Review
  • Open Access
10 Citations
3,348 Views
13 Pages

20 July 2024

Introduction: There is a significant gap in the literature concerning the effective management of second-line therapy for patients with metastatic renal cell carcinoma (RCC) who have received immune checkpoint inhibitors (ICIs). Most of the published...

(This article belongs to the Special Issue Advances in Drug Delivery for Cancer Therapy)
  • Systematic Review
  • Open Access
42 Citations
7,840 Views
24 Pages

Chemotoxicity and Associated Risk Factors in Colorectal Cancer: A Systematic Review and Meta-Analysis

  • Claire J. Han,
  • Xia Ning,
  • Christin E. Burd,
  • Daniel J. Spakowicz,
  • Fode Tounkara,
  • Matthew F. Kalady,
  • Anne M. Noonan,
  • Susan McCabe and
  • Diane Von Ah

20 July 2024

Background: Colorectal cancer (CRC) patients experience multiple types of chemotoxicity affecting treatment compliance, survival, and quality of life (QOL). Prior research shows clinician-reported chemotoxicity (i.e., grading scales or diagnostic cod...

(This article belongs to the Topic Advances in Colorectal Cancer Therapy)
  • Article
  • Open Access
2 Citations
4,124 Views
19 Pages

Fibroblasts Promote Resistance to KRAS Silencing in Colorectal Cancer Cells

  • Susana Mendonça Oliveira,
  • Patrícia Dias Carvalho,
  • André Serra-Roma,
  • Patrícia Oliveira,
  • Andreia Ribeiro,
  • Joana Carvalho,
  • Flávia Martins,
  • Ana Luísa Machado,
  • Maria José Oliveira and
  • Sérgia Velho

20 July 2024

Colorectal cancer (CRC) responses to KRAS-targeted inhibition have been limited due to low response rates, the mechanisms of which remain unknown. Herein, we explored the cancer-associated fibroblasts (CAFs) secretome as a mediator of resistance to K...

(This article belongs to the Special Issue RAS Signaling Pathway in Cancer Therapy)
  • Systematic Review
  • Open Access
6 Citations
3,988 Views
17 Pages

Multi-Omics Classification of Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis

  • Laura Alaimo,
  • Sara Boggio,
  • Giovanni Catalano,
  • Giuseppe Calderone,
  • Edoardo Poletto,
  • Mario De Bellis,
  • Tommaso Campagnaro,
  • Corrado Pedrazzani,
  • Simone Conci and
  • Andrea Ruzzenente

20 July 2024

Intrahepatic cholangiocarcinoma (ICC) is a heterogeneous disease characterized by a dismal prognosis. Various attempts have been made to classify ICC subtypes with varying prognoses, but a consensus has yet to be reached. This systematic review aims...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
5 Citations
2,548 Views
14 Pages

20 July 2024

Antiandrogen is part of the standard-of-care treatment option for metastatic prostate cancer. However, prostate cancers frequently relapse, and the underlying resistance mechanism remains incompletely understood. This study seeks to investigate wheth...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
30 Citations
10,426 Views
25 Pages

19 July 2024

Parathyroid pathologies are suspected based on the biochemical alterations and clinical manifestations, and the predominant roles of imaging in primary hyperparathyroidism are localisation of tumour within parathyroid glands, surgical planning, and t...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
7 Citations
2,888 Views
12 Pages

Baseline Blood CD8+ T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer

  • Hanneke Kievit,
  • M. Benthe Muntinghe-Wagenaar,
  • Wayel H. Abdulahad,
  • Abraham Rutgers,
  • Lucie B. M. Hijmering-Kappelle,
  • Birgitta I. Hiddinga,
  • J. Fred Ubbels,
  • Robin Wijsman,
  • Marcel J. van der Leij and
  • T. Jeroen N. Hiltermann
  • + 5 authors

19 July 2024

Background: Tumor-infiltrating immune cells have been correlated with prognosis for patients treated with immune checkpoint inhibitor (ICI) treatment of various cancers. However, no robust biomarker has been described to predict treatment response ye...

(This article belongs to the Special Issue Novel Biomarkers in Non-Small Cell Lung Cancer (NSCLC))
  • Article
  • Open Access
2 Citations
3,395 Views
18 Pages

Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [18F]FDG-PET/MRI

  • Lena Zachhuber,
  • Thomas Filip,
  • Behrang Mozayani,
  • Mathilde Löbsch,
  • Stefan Scheiner,
  • Petra Vician,
  • Johann Stanek,
  • Marcus Hacker,
  • Thomas H. Helbich and
  • Claudia Kuntner
  • + 2 authors

19 July 2024

Cholangiocarcinoma (CCA) is a type of primary liver cancer originating from the biliary tract epithelium, characterized by limited treatment options for advanced cases and low survival rates. This study aimed to establish an orthotopic mouse model fo...

(This article belongs to the Special Issue Advances in Oncological Imaging)
  • Article
  • Open Access
15 Citations
4,655 Views
20 Pages

Bevacizumab-Based Therapies in Malignant Tumors—Real-World Data on Effectiveness, Safety, and Cost

  • Elena Chitoran,
  • Vlad Rotaru,
  • Sinziana-Octavia Ionescu,
  • Aisa Gelal,
  • Cristina-Mirela Capsa,
  • Roxana-Elena Bohiltea,
  • Madalina-Nicoleta Mitroiu,
  • Dragos Serban,
  • Giuseppe Gullo and
  • Laurentiu Simion
  • + 1 author

19 July 2024

Overall, it is estimated that more than 3,500,000 patients have received Bevacizumab as part of systemic oncologic treatment. Bevacizumab and its biosimilars are currently marketed in over 130 countries. Given the wide usage of Bevacizumab in current...

(This article belongs to the Special Issue Preclinical and Clinical Research on the Efficacy of Anticancer Drugs)
  • Article
  • Open Access
16 Citations
5,329 Views
13 Pages

Post-Progression Analysis of EGFR-Mutant NSCLC Following Osimertinib Therapy in Real-World Settings

  • Ilaria Attili,
  • Carla Corvaja,
  • Gianluca Spitaleri,
  • Pamela Trillo Aliaga,
  • Ester Del Signore,
  • Antonio Passaro and
  • Filippo de Marinis

19 July 2024

Background: Platinum-based chemotherapy is the current standard treatment option in patients with EGFR-mutant non-small-cell lung cancer (NSCLC) who progress on osimertinib. However, outcomes with chemotherapy are dismal, and the treatment of central...

(This article belongs to the Special Issue Advances in Epidermal Growth Factor Receptor-Driven Non-Small-Cell Lung Cancer: Diagnostic Technologies and Therapeutic Strategies)
  • Correction
  • Open Access
1,172 Views
2 Pages

Correction: Krayem et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. Cancers 2020, 12, 512

  • Mohammad Krayem,
  • Philippe Aftimos,
  • Ahmad Najem,
  • Tim van den Hooven,
  • Adriënne van den Berg,
  • Liesbeth Hovestad-Bijl,
  • Rik de Wijn,
  • Riet Hilhorst,
  • Rob Ruijtenbeek and
  • Ghanem E. Ghanem
  • + 4 authors

19 July 2024

In the original article [...]

  • Article
  • Open Access
2 Citations
2,264 Views
13 Pages

Stem Cell Mobilization Performed with Different Doses of Cytarabine in Plasma Cell Myeloma Patients Relapsing after Previous Autologous Hematopoietic Cell Transplantation—A Multicenter Report by the Polish Myeloma Study Group

  • Joanna Drozd-Sokołowska,
  • Anna Waszczuk-Gajda,
  • Magdalena Topczewska,
  • Martyna Maciejewska,
  • Magdalena Dutka,
  • Jan Maciej Zaucha,
  • Anna Szmigielska-Kapłon,
  • Mateusz Nowicki,
  • Magdalena Olszewska-Szopa and
  • Grzegorz Władysław Basak
  • + 16 authors

19 July 2024

Salvage autologous hematopoietic cell transplantation (auto-HCT) may be used to treat relapse of plasma cell myeloma occurring after previous auto-HCT. When an insufficient number of hematopoietic stem cells have been stored from the initial harvest,...

(This article belongs to the Section Transplant Oncology)
  • Review
  • Open Access
29 Citations
9,838 Views
30 Pages

Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors and CAR-T Cell Therapy: A Comprehensive Imaging-Based Review

  • Chiara Pozzessere,
  • Bianca Mazini,
  • Patrick Omoumi,
  • Mario Jreige,
  • Leslie Noirez,
  • Antonia Digklia,
  • François Fasquelle,
  • Christine Sempoux and
  • Clarisse Dromain

19 July 2024

Immunotherapy has revolutionized oncology care, improving patient outcomes in several cancers. However, these therapies are also associated with typical immune-related adverse events due to the enhanced inflammatory and immune response. These toxicit...

(This article belongs to the Special Issue How to Properly Diagnose and Treat Immune-Related Adverse Events during Immunotherapy in Patients with Cancer: Discussion between Specialists)
  • Article
  • Open Access
1 Citations
4,784 Views
20 Pages

Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study

  • Maximilian Hochmair,
  • Angelika Terbuch,
  • David Lang,
  • Christian Trockenbacher,
  • Florian Augustin,
  • Bahil Ghanim,
  • Dominik Maurer,
  • Hossein Taghizadeh,
  • Christoph Kamhuber and
  • Konrad Hötzenecker
  • + 14 authors

19 July 2024

This was a retrospective study of the profile and initial treatments of adults diagnosed with early-stage (ES) non-small cell lung cancer (NSCLC) during January 2018–December 2021 at 16 leading hospital institutions in Austria, excluding patien...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
5 Citations
2,710 Views
9 Pages

Impact of Robotic Assistance on Minimally Invasive Surgery for Type II Endometrial Cancer: A National Cancer Database Analysis

  • Kelly Lamiman,
  • Michael Silver,
  • Nicole Goncalves,
  • Michael Kim and
  • Ioannis Alagkiozidis

19 July 2024

The objective of this study is to compare the overall survival (OS) and surgical outcomes between conventional laparoscopy and robot-assisted laparoscopy (RAL) in women with type II endometrial cancer. We identified a large cohort of women who underw...

(This article belongs to the Special Issue Clinical Research Advances in Endometrial Carcinoma)
  • Review
  • Open Access
14 Citations
13,075 Views
16 Pages

Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management

  • Marianne Zoghbi,
  • Mohammad Jad Moussa,
  • Jim Dagher,
  • Elio Haroun,
  • Aiham Qdaisat,
  • Emad D. Singer,
  • Yara E. Karam,
  • Sai-Ching J. Yeung and
  • Patrick Chaftari

19 July 2024

Brain metastases (BMs) are the most prevalent type of cerebral tumor, significantly affecting survival. In adults, lung cancer, breast cancer, and melanoma are the primary cancers associated with BMs. Symptoms often result from brain compression, and...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
43 Citations
20,564 Views
33 Pages

The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management

  • Andrea Amaroli,
  • Isabella Panfoli,
  • Matteo Bozzo,
  • Sara Ferrando,
  • Simona Candiani and
  • Silvia Ravera

18 July 2024

Curcumin, a polyphenolic compound derived from Curcuma longa, exhibits significant therapeutic potential in cancer management. This review explores curcumin’s mechanisms of action, the challenges related to its bioavailability, and its enhancem...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
4 Citations
2,738 Views
13 Pages

Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation

  • Alexandra Charalampopoulou,
  • Amelia Barcellini,
  • Andrea Peloso,
  • Alessandro Vanoli,
  • Stefania Cesari,
  • Antonia Icaro Cornaglia,
  • Margarita Bistika,
  • Stefania Croce,
  • Lorenzo Cobianchi and
  • Angelica Facoetti
  • + 6 authors

18 July 2024

Introduction: Decellularized extracellular matrix (ECM) bioscaffolds have emerged as a promising three-dimensional (3D) model, but so far there are no data concerning their use in radiobiological studies. Material and Methods: We seeded two well-know...

(This article belongs to the Section Methods and Technologies Development)
  • Article
  • Open Access
4 Citations
1,939 Views
15 Pages

Histomolecular Validation of [18F]-FACBC in Gliomas Using Image-Localized Biopsies

  • Benedikte Emilie Vindstad,
  • Anne Jarstein Skjulsvik,
  • Lars Kjelsberg Pedersen,
  • Erik Magnus Berntsen,
  • Ole Skeidsvoll Solheim,
  • Tor Ingebrigtsen,
  • Ingerid Reinertsen,
  • Håkon Johansen,
  • Live Eikenes and
  • Anna Maria Karlberg

18 July 2024

Background: Gliomas have a heterogeneous nature, and identifying the most aggressive parts of the tumor and defining tumor borders are important for histomolecular diagnosis, surgical resection, and radiation therapy planning. This study evaluated [1...

(This article belongs to the Section Methods and Technologies Development)
  • Review
  • Open Access
16 Citations
5,054 Views
15 Pages

18 July 2024

SerpinB3, a member of the serine-protease inhibitor family, has emerged as a crucial player in various physiological and pathological processes. Initially identified as an oncogenic factor in squamous cell carcinomas, SerpinB3’s intricate invol...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
3 Citations
2,254 Views
16 Pages

Machine Learning Analysis in Diffusion Kurtosis Imaging for Discriminating Pediatric Posterior Fossa Tumors: A Repeatability and Accuracy Pilot Study

  • Ioan Paul Voicu,
  • Francesco Dotta,
  • Antonio Napolitano,
  • Massimo Caulo,
  • Eleonora Piccirilli,
  • Claudia D’Orazio,
  • Andrea Carai,
  • Evelina Miele,
  • Maria Vinci and
  • Giovanna Stefania Colafati
  • + 6 authors

18 July 2024

Background and purpose: Differentiating pediatric posterior fossa (PF) tumors such as medulloblastoma (MB), ependymoma (EP), and pilocytic astrocytoma (PA) remains relevant, because of important treatment and prognostic implications. Diffusion kurtos...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
7 Citations
2,597 Views
13 Pages

18 July 2024

The prognostic significance of tumor size in T3b differentiated thyroid cancer (DTC) remains debated and underexplored. This study aimed to examine the varying impact of T3b based on tumor size, analyzing disease-specific survival, disease-free survi...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
4 Citations
3,365 Views
18 Pages

Baseline Association between Healthy Eating Index-2015 and Health-Related Quality of Life in Breast Cancer Patients Enrolled in a Randomized Trial

  • Giuseppe Porciello,
  • Sergio Coluccia,
  • Sara Vitale,
  • Elvira Palumbo,
  • Assunta Luongo,
  • Maria Grimaldi,
  • Rosa Pica,
  • Melania Prete,
  • Ilaria Calabrese and
  • the DEDiCa Study Group
  • + 20 authors

18 July 2024

Health-related quality of life (HRQoL) represents one of the most concerning aspects for cancer patients. The Healthy Eating Index (HEI) is an a priori diet quality index directly associated with health outcomes and HRQoL in cancer survivors in North...

(This article belongs to the Section Cancer Survivorship and Quality of Life)
  • Article
  • Open Access
2 Citations
5,799 Views
12 Pages

Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study

  • Linda Titus,
  • Elizabeth E. Hatch,
  • Kimberly A. Bertrand,
  • Julie R. Palmer,
  • William C. Strohsnitter,
  • Dezheng Huo,
  • Michael Curry,
  • Marianne Hyer,
  • Kjersti Aagaard and
  • Rebecca Troisi
  • + 1 author

18 July 2024

Background: Females exposed prenatally to diethylstilbestrol (DES) have an elevated risk of cervical dysplasia, breast cancer, and clear cell adenocarcinoma (CCA) of the cervix/vagina. Testicular cancer risk is increased in prenatally exposed males....

(This article belongs to the Special Issue Feature Paper in Section 'Cancer Epidemiology and Prevention' in 2024)
  • Review
  • Open Access
8 Citations
3,109 Views
13 Pages

The Importance of Extracellular Vesicle Screening in Gastric Cancer: A 2024 Update

  • Vasile Bintintan,
  • Claudia Burz,
  • Irena Pintea,
  • Adriana Muntean,
  • Diana Deleanu,
  • Iulia Lupan and
  • Gabriel Samasca

18 July 2024

Extracellular vesicles, or EVs, are membrane-bound nanocompartments produced by tumor cells. EVs carry proteins and nucleic acids from host cells to target cells, where they can transfer lipids, proteomes, and genetic material to change the function...

(This article belongs to the Topic Extracellular Vesicles in Cancer Diagnosis and Treatment)
  • Article
  • Open Access
6 Citations
2,721 Views
14 Pages

Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection

  • Pompilia Radu,
  • Chiara Becchetti,
  • Jonas Schropp,
  • Patrick Schmid,
  • Patrizia Künzler-Heule,
  • Joachim Mertens,
  • Darius Moradpour,
  • Beat Müllaupt,
  • David Semela and
  • Swiss Hepatitis C Cohort Study
  • + 6 authors

18 July 2024

Introduction: The use of direct-acting antivirals (DAAs) has drastically changed the management of HCV-infected patients by achieving a 95–98% sustained virologic response (SVR) and reducing morbidity and mortality in this population. However,...

(This article belongs to the Section Infectious Agents and Cancer)
  • Review
  • Open Access
8 Citations
8,451 Views
13 Pages

18 July 2024

The most recent (eighth) edition of the American Joint Committee on Cancer (AJCC) staging system divides invasive cutaneous melanoma into two broad groups: “low-risk” (stage IA–IIA) and “high-risk” (stage IIB–IV)....

(This article belongs to the Special Issue Contemporary Surgical Management of Melanoma)
  • Review
  • Open Access
45 Citations
16,917 Views
16 Pages

Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Narrative Review and Proposed Theoretical Model

  • Kimberley T. Lee,
  • Hailey W. Bulls,
  • Aasha I. Hoogland,
  • Brian W. James,
  • Claudia B. Colon-Echevarria and
  • Heather S. L. Jim

18 July 2024

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating symptom experienced by cancer survivors. Despite the burden of CIPN-related symptoms, interventions remain limited. Objectives: This narrative review seeks to...

(This article belongs to the Special Issue Cancer Survivorship: During and After Treatment)
  • Article
  • Open Access
4 Citations
2,174 Views
13 Pages

Changes in Time to Initial Physician Contact and Cancer Stage Distribution during the COVID-19 Pandemic in Patients with Head and Neck Squamous Cell Carcinoma at a Large Hungarian Cancer Center

  • Éva Szabó,
  • Eszter Kopjár,
  • László Rumi,
  • Árpád Boronkai,
  • Szabolcs Bellyei,
  • Zoltán Gyöngyi,
  • Antal Zemplényi,
  • Balázs Sütő,
  • János Girán and
  • István Szanyi
  • + 2 authors

18 July 2024

The aim of our study was to compare the characteristics and time to initial physician contact in patients with head and neck squamous cell carcinoma (HNSCC) before and during the COVID-19 pandemic at a large Hungarian cancer center. This was a retros...

(This article belongs to the Special Issue How COVID-19 Affects Cancer Patients)
  • Systematic Review
  • Open Access
14 Citations
4,743 Views
10 Pages

Systematic Review and Meta-Analysis of Particle Beam Therapy versus Photon Radiotherapy for Skull Base Chordoma: TRP-Chordoma 2024

  • Takashi Saito,
  • Masashi Mizumoto,
  • Yoshiko Oshiro,
  • Shosei Shimizu,
  • Yinuo Li,
  • Masatoshi Nakamura,
  • Sho Hosaka,
  • Kei Nakai,
  • Takashi Iizumi and
  • Hideyuki Sakurai
  • + 4 authors

17 July 2024

[Objective] The aim of this study was to compare the efficacy of particle beam therapy (PT) with photon radiotherapy (RT) for treatment of skull base chordoma. [Methods] A systematic review was conducted for skull base chordoma treated with PT or pho...

(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
  • Article
  • Open Access
4 Citations
3,029 Views
17 Pages

Impact of Genomic Mutation on Melanoma Immune Microenvironment and IFN-1 Pathway-Driven Therapeutic Responses

  • Fátima María Mentucci,
  • Elisa Ayelén Romero Nuñez,
  • Agustina Ercole,
  • Valentina Silvetti,
  • Jessica Dal Col and
  • María Julia Lamberti

17 July 2024

The BRAFV600E mutation, found in approximately 50% of melanoma cases, plays a crucial role in the activation of the MAPK/ERK signaling pathway, which promotes tumor cell proliferation. This study aimed to evaluate its impact on the melanoma immune mi...

(This article belongs to the Special Issue Metastatic Melanoma: From Gene Profiling to Targeted Therapy)
  • Article
  • Open Access
18 Citations
4,429 Views
15 Pages

Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study

  • Alex Juárez,
  • María Queralt Salas,
  • Alexandra Pedraza,
  • María Suárez-Lledó,
  • Luís Gerardo Rodríguez-Lobato,
  • María Teresa Solano,
  • Anna Serrahima,
  • Meritxell Nomdedeu,
  • Joan Cid and
  • Carmen Martínez
  • + 7 authors

17 July 2024

PTCY 50 mg/kg/day on days +3/+4 is an excellent strategy to prevent GVHD. However, its use is associated with adverse outcomes such as delayed engraftment, increased risk of infection, and cardiac complications. This pilot study evaluates the efficac...

(This article belongs to the Special Issue Immunotherapy and Transplantation in the Era of Transplant Oncology)
  • Article
  • Open Access
10 Citations
4,312 Views
17 Pages

The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer

  • Woong Ki Park,
  • Seok Jin Nam,
  • Seok Won Kim,
  • Jeong Eon Lee,
  • Jonghan Yu,
  • Se Kyung Lee,
  • Jai Min Ryu and
  • Byung Joo Chae

17 July 2024

TNBC is noted for its aggressive behavior and poor prognosis. Recently developed HER2 target agents have shown potential benefit even in HER2-low expressing breast cancers. This study retrospectively analyzed 2542 non-metastatic TNBC patients from 20...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Article
  • Open Access
6 Citations
3,440 Views
10 Pages

Revolutionizing Skin Cancer Triage: The Role of Patient-Initiated Teledermoscopy in Remote Diagnosis

  • Emilie A. Foltz,
  • Joanna Ludzik,
  • Sancy Leachman,
  • Elizabeth Stoos,
  • Teri Greiling,
  • Noelle Teske,
  • Lara Clayton,
  • Alyssa L. Becker and
  • Alexander Witkowski

17 July 2024

Introduction: Teledermatology, defined as the use of remote imaging technologies to provide dermatologic healthcare services to individuals in a distant setting, has grown considerably in popularity since its widespread implementation during the COVI...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
1 Citations
2,416 Views
15 Pages

Non-Invasive 3D Breast Tumor Localization: A Viable Alternative to Invasive Tumor Marking

  • Dragana Bjelica,
  • Natasa Colakovic,
  • Svetlana Opric,
  • Darko Zdravkovic,
  • Barbara Loboda,
  • Simona Petricevic,
  • Milan Gojgic,
  • Ognjen Zecic,
  • Zlatko Skuric and
  • Nebojsa Ivanovic
  • + 1 author

17 July 2024

Background: We present a detailed description and the preliminary results of our original technique for non-invasive three-dimensional tumor localization in the breast, which was created as an alternative to standard invasive tumor marking before neo...

(This article belongs to the Section Methods and Technologies Development)

of 3

XFacebookLinkedIn
Cancers - ISSN 2072-6694